Dupixent 200 MG/1.14 ML syring 1.14ML
Ended Awarded
- Contract number
- SPE2DB25FNAUP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,947
Award facts
- Contract value 100% obligated
- $5,947.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $5,947.38 to AmerisourceBergen Drug Corp for the supply of Dupixent 200 mg/1.14 mL syringes on September 17, 2025, with an ultimate completion date of September 18, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and is being performed at the contractor's corporate headquarters in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat various inflammatory conditions including atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps, and represents a specialized pharmaceutical product within the federal medical supply chain.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen Drug Corp's extensive federal contract portfolio and demonstrated capability to meet competitive procurement requirements position the company as a critical vendor within the Department of Defense medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FNAUP?
SPE2DB25FNAUP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FNAUP worth?
The government has obligated $5,947 on SPE2DB25FNAUP.
Is contract SPE2DB25FNAUP an order under another contract?
Yes. SPE2DB25FNAUP is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB25FNAUP competed?
The extent of competition for SPE2DB25FNAUP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award